DEA issues warning over counterfeit prescription pills from Mexico containing fentanyl

DEA Counterfeit Fentanyl Pill Warning release final Nov 2019
The U.S. Drug Enforcement Administration has issued a warning about large amounts of counterfeit prescription pills containing fentanyl coming from Mexico.

Mexican drug cartels are manufacturing and importing mass quantities of pills and, based on a sampling of tablets seized nationwide between Jan. and Mar. 2019, the DEA found that 27% contained potentially lethal doses of fentanyl.

“Capitalizing on the opioid epidemic and prescription drug abuse in the United States, drug trafficking organizations are now sending counterfeit pills made with fentanyl in bulk to the United States for distribution,” said DEA Acting Administrator Uttam Dhillon. “Counterfeit pills that contain fentanyl and fentanyl-laced heroin are responsible for thousands of opioid-related deaths in the United States each year.

According to the Centers for Disease Control and Prevention, fentanyl is used as an opioid pain reliever, treating severe pain like some forms of cancer.

“It is 50 to 100 times more potent than morphine,” states the CDC on their website. “It is prescribed in the form of [adhesive] patches or lozenges.”

DEA Special Agent in Charge Brian D. Boyle highlights that fentanyl and other highly potent synthetic opioids are the primary problems behind the opioid crisis in New England.

“Fentanyl [is] involved in more deaths than any other illicit drug,” said Boyle.

Massachusetts has been ranked among the top ten states with the highest rates of drug overdose deaths involving opioids with 1,913 drug overdose deaths involving opioids in 2017. Opioid deaths in Massachusetts are twice as high at the national average, according to the National Institute on Drug Abuse.

According to the DEA, a lethal dose of fentanyl is estimated to be just two milligrams but can vary based on an individual’s body size, tolerance, and amount of usage.



Similarly to the false climate change narrative regarding the spread of ticks and Lyme disease, there is another false mantra – that those requiring pain medications are behind the “opioid crisis.”  Nothing could be further from the truth.

This article from The Guardian, states that the upsurge in prescription opioids was in response to an under prescription crisis and that those suffering with severe and chronic pain were left to “writhe in pain” until policies changed in the 70s and 80s. The author points out that the opioid scare campaign of today mimics a scare campaign of history:

You know something is wrong when a stage four cancer patient is sent home with Tylenol.

For more:

Now, thanks to the Washington Post’s investigation, we learn that the DEA directly negotiated with the drug industry to grant opioid manufacturers selective immunity from criminal seizure and prosecution. Is anyone really surprised? This has been the DEA’s business model for decades.

The following graphic (see link above), published by the Washington Post, reveals that at least 56 DEA and Justice Dept. officials left their government jobs to work for the pharmaceutical industry.